{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T12:57:12Z","timestamp":1788785832694,"version":"build-2803163510"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T00:00:00Z","timestamp":1756080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T00:00:00Z","timestamp":1756080000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100021787","name":"Wachemo University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100021787","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-15855-3","type":"journal-article","created":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T19:11:29Z","timestamp":1756149089000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Antitubercular drug induced liver injury among tuberculosis patients in central Ethiopia"],"prefix":"10.1038","volume":"15","author":[{"given":"Zelalem","family":"Petros","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anteneh","family":"Tamirat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wondimu","family":"Assefa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,25]]},"reference":[{"key":"15855_CR1","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1007\/s12072-023-10633-7","volume":"18","author":"Y Mao","year":"2024","unstructured":"Mao, Y. et al. Chinese guideline for the diagnosis and treatment of drug-induced liver injury: an update. Hepatol. Int. 18, 384\u2013419. https:\/\/doi.org\/10.1007\/s12072-023-10633-7 (2024).","journal-title":"Hepatol. Int."},{"key":"15855_CR2","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s12664-024-01674-3","volume":"44","author":"H Gopalakrishna","year":"2025","unstructured":"Gopalakrishna, H. & Chalasani, N. Drug-induced liver injury due to first-line antituberculosis medications in india: A major hindrance to achieve the goal of tuberculosis elimination. Indian J. Gastroenterol. 44, 4\u20137. https:\/\/doi.org\/10.1007\/s12664-024-01674-3 (2025).","journal-title":"Indian J. Gastroenterol."},{"key":"15855_CR3","doi-asserted-by":"publisher","first-page":"e70138","DOI":"10.1111\/liv.70138","volume":"45","author":"HC Devarbhavi","year":"2025","unstructured":"Devarbhavi, H. C. & Andrade, R. J. Natural history of idiosyncratic Drug-Induced liver injury and prognostic models. Liver Int. 45, e70138. https:\/\/doi.org\/10.1111\/liv.70138 (2025).","journal-title":"Liver Int."},{"key":"15855_CR4","doi-asserted-by":"publisher","first-page":"e70686","DOI":"10.1002\/hsr2.70686","volume":"8","author":"RR Pradhan","year":"2025","unstructured":"Pradhan, R. R., Yadav, A. K. & Incidence Clinical features, associated factors and outcomes of intensive phase antituberculosis drug induced liver injury among patients with tuberculosis at a tertiary care hospital in nepal: A descriptive Cross-Sectional study. Health Sci. Rep. 8, e70686. https:\/\/doi.org\/10.1002\/hsr2.70686 (2025).","journal-title":"Health Sci. Rep."},{"key":"15855_CR5","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.2147\/idr.s519211","volume":"18","author":"S Zhang","year":"2025","unstructured":"Zhang, S., Dong, N., Wang, L., Lu, Y. & Chen, X. Clinical features of Anti-Tuberculosis Drug-Induced liver injury and risk factors for severe cases: A retrospective study in China. Infect. Drug Resist. 18, 2065\u20132078. https:\/\/doi.org\/10.2147\/idr.s519211 (2025).","journal-title":"Infect. Drug Resist."},{"key":"15855_CR6","doi-asserted-by":"publisher","unstructured":"Wang, N. et al. Incidence and temporal trend of antituberculosis drug-induced liver injury: A systematic review and meta-analysis. J. Trop. Med. 8266878. https:\/\/doi.org\/10.1155\/2022\/8266878 (2022).","DOI":"10.1155\/2022\/8266878"},{"key":"15855_CR7","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1111\/j.1440-1746.2007.05207.x","volume":"23","author":"A Tostmann","year":"2008","unstructured":"Tostmann, A. et al. Antituberculosis drug-induced hepatotoxicity: concise up-to-date review. J. Gastroenterol. Hepatol. 23, 192\u2013202. https:\/\/doi.org\/10.1111\/j.1440-1746.2007.05207.x (2008).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"15855_CR8","doi-asserted-by":"publisher","first-page":"e074866","DOI":"10.1136\/bmj-2023-074866","volume":"383","author":"WS Lim","year":"2023","unstructured":"Lim, W. S., Avery, A., Kon, O. M. & Dedicoat, M. Anti-tuberculosis drug-induced liver injury. BMJ 383, e074866. https:\/\/doi.org\/10.1136\/bmj-2023-074866 (2023).","journal-title":"BMJ"},{"issue":"6","key":"15855_CR9","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1111\/jcpt.12702","volume":"43","author":"MT Angamo","year":"2018","unstructured":"Angamo, M. T., Chalmers, L., Curtain, C. M., Yilma, D. & Bereznicki, L. Mortality from adverse drug reaction-related hospitalizations in south-west ethiopia: A cross-sectional study. J. Clin. Pharm. Ther. 43 (6), 790\u2013798. https:\/\/doi.org\/10.1111\/jcpt.12702 (2018).","journal-title":"J. Clin. Pharm. Ther."},{"key":"15855_CR10","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1007\/s12072-021-10144-3","volume":"15","author":"H Devarbhavi","year":"2021","unstructured":"Devarbhavi, H. et al. Drug-induced liver injury: Asia Pacific association of study of liver consensus guidelines. Hepatol. Int. 15, 258\u2013282. https:\/\/doi.org\/10.1007\/s12072-021-10144-3 (2021).","journal-title":"Hepatol. Int."},{"key":"15855_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/hmer.s290542","volume":"13","author":"Y Molla","year":"2021","unstructured":"Molla, Y., Wubetu, M. & Dessie, B. Anti-Tuberculosis drug induced hepatotoxicity and associated factors among tuberculosis patients at selected hospitals, Ethiopia. Hepat. Med.. 13, 1\u20138. https:\/\/doi.org\/10.2147\/hmer.s290542 (2021).","journal-title":"Hepat. Med. 2021"},{"key":"15855_CR12","doi-asserted-by":"publisher","first-page":"e0241346","DOI":"10.1371\/journal.pone.0241346","volume":"15","author":"LK Gezahegn","year":"2020","unstructured":"Gezahegn, L. K., Argaw, E., Assefa, B., Geberesilassie, A. & Hagazi, M. Magnitude, outcome, and associated factors of anti-tuberculosis drug-induced hepatitis among tuberculosis patients in a tertiary hospital in North ethiopia: A cross-sectional study. PLoS One. 15, e0241346. https:\/\/doi.org\/10.1371\/journal.pone.0241346 (2020).","journal-title":"PLoS One"},{"key":"15855_CR13","doi-asserted-by":"publisher","first-page":"e1809","DOI":"10.1371\/journal.pone.0001809","volume":"3","author":"G Yimer","year":"2008","unstructured":"Yimer, G. et al. Anti-tuberculosis therapy-induced hepatotoxicity among Ethiopian HIV-positive and negative patients. PLoS One. 3, e1809. https:\/\/doi.org\/10.1371\/journal.pone.0001809 (2008).","journal-title":"PLoS One"},{"key":"15855_CR14","unstructured":"WHO. WHO Consolidated Guidelines on Tuberculosis: Module 4: Treatment - Drug-susceptible Tuberculosis Treatment (World Health Organization, 2022)."},{"key":"15855_CR15","doi-asserted-by":"publisher","first-page":"425","DOI":"10.14218\/jcth.2022.00077","volume":"11","author":"D Huang","year":"2023","unstructured":"Huang, D. et al. Time of liver function abnormal identification on prediction of the risk of Anti-tuberculosis-induced liver injury. J. Clin. Transl Hepatol. 11, 425\u2013432. https:\/\/doi.org\/10.14218\/jcth.2022.00077 (2023).","journal-title":"J. Clin. Transl Hepatol."},{"issue":"6","key":"15855_CR16","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1038\/clpt.2011.58","volume":"89","author":"GP Aithal","year":"2011","unstructured":"Aithal, G. P. et al. Case definition and phenotype standardization in drug-induced liver injury. Clin. Pharmacol. Ther. 89 (6), 806\u2013815. https:\/\/doi.org\/10.1038\/clpt.2011.58 (2011).","journal-title":"Clin. Pharmacol. Ther."},{"issue":"4","key":"15855_CR17","doi-asserted-by":"publisher","first-page":"e94271","DOI":"10.1371\/journal.pone.0094271","volume":"9","author":"G Yimer","year":"2014","unstructured":"Yimer, G. et al. Evaluation of patterns of liver toxicity in patients on antiretroviral and anti-tuberculosis drugs, a prospective four arm observational study in Ethiopian patients. PloS One. 9 (4), e94271. https:\/\/doi.org\/10.1371\/journal.pone.0094271 (2014).","journal-title":"PloS One"},{"key":"15855_CR18","doi-asserted-by":"publisher","first-page":"122","DOI":"10.34172\/aim.2024.19","volume":"27","author":"F Abbaspour","year":"2024","unstructured":"Abbaspour, F. & Hasannezhad, M. Managing hepatotoxicity caused by Anti-tuberculosis drugs: A comparative study of approaches. Arch. Iran. Med. 27, 122\u2013126. https:\/\/doi.org\/10.34172\/aim.2024.19 (2024).","journal-title":"Arch. Iran. Med."},{"key":"15855_CR19","doi-asserted-by":"publisher","unstructured":"Wen, B., Zhang, G., Zhan, C., Chen, C. & Yi, H. The 2024 Revision of the Declaration of Helsinki: A Modern Ethical Framework for Medical Research, vol. 101,  371\u2013382 https:\/\/doi.org\/10.1093\/postmj\/qgae181 (2025).","DOI":"10.1093\/postmj\/qgae181"},{"key":"15855_CR20","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s12072-008-9085-y","volume":"2","author":"HA Makhlouf","year":"2008","unstructured":"Makhlouf, H. A., Helmy, A., Fawzy, E., El-Attar, M. & Rashed, H. A. A prospective study of antituberculous drug-induced hepatotoxicity in an area endemic for liver diseases. Hepatol. Int. 2, 353\u2013360. https:\/\/doi.org\/10.1007\/s12072-008-9085-y (2008).","journal-title":"Hepatol. Int."},{"key":"15855_CR21","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.ijmyco.2015.10.002","volume":"5","author":"A Wondwossen","year":"2016","unstructured":"Wondwossen, A., Waqtola, C. & Gemeda, A. Incidence of antituberculosis-drug-induced hepatotoxicity and associated risk factors among tuberculosis patients in Dawro zone, South ethiopia: A cohort study. Int. J. Mycobacteriol. 5, 14\u201320. https:\/\/doi.org\/10.1016\/j.ijmyco.2015.10.002 (2016).","journal-title":"Int. J. Mycobacteriol"},{"key":"15855_CR22","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s12664-024-01643-w","volume":"44","author":"R Kumar","year":"2025","unstructured":"Kumar, R., Kumar, A. & Patel, R. Incidence and risk factors of antituberculosis drug-induced liver injury in india: A systematic review and meta-analysis. Indian J. Gastroenterol. 44, 35\u201346. https:\/\/doi.org\/10.1007\/s12664-024-01643-w (2025).","journal-title":"Indian J. Gastroenterol."},{"key":"15855_CR23","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1177\/02537176211073764","volume":"44","author":"CR Andrade","year":"2022","unstructured":"Andrade, C. R. & Design Cohort studies. Indian J. Psychol. Med. 44, 189\u2013191. https:\/\/doi.org\/10.1177\/02537176211073764 (2022).","journal-title":"Indian J. Psychol. Med."},{"key":"15855_CR24","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1053\/j.gastro.2019.02.002","volume":"156","author":"T Shen","year":"2019","unstructured":"Shen, T. et al. Incidence and etiology of Drug-Induced liver injury in Mainland China. Gastroenterology 156, 2230\u20132241. https:\/\/doi.org\/10.1053\/j.gastro.2019.02.002 (2019).","journal-title":"Gastroenterology"},{"key":"15855_CR25","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ijmyco.2015.10.001","volume":"5","author":"SE Isa","year":"2016","unstructured":"Isa, S. E. et al. Antituberculosis drugs and hepatotoxicity among hospitalized patients in jos, Nigeria. Int. J. Mycobacteriol. 5, 21\u201326. https:\/\/doi.org\/10.1016\/j.ijmyco.2015.10.001 (2016).","journal-title":"Int. J. Mycobacteriol"},{"key":"15855_CR26","doi-asserted-by":"publisher","unstructured":"Abbara, A. et al. Drug-induced liver injury from antituberculous treatment: a retrospective study from a large TB centre in the UK. BMC Infect. Dis. 17. https:\/\/doi.org\/10.1186\/s12879-017-2330-z (2017).","DOI":"10.1186\/s12879-017-2330-z"},{"key":"15855_CR27","doi-asserted-by":"publisher","first-page":"100665","DOI":"10.1016\/j.ijregi.2025.100665","volume":"15","author":"S Mukura","year":"2025","unstructured":"Mukura, S. & Ruenwilai, P. Anti-tuberculosis drug-induced hepatotoxicity and associated risk factors among patients with pulmonary tuberculosis at a tertiary care hospital in Thailand. IJID Reg. 15, 100665. https:\/\/doi.org\/10.1016\/j.ijregi.2025.100665 (2025).","journal-title":"IJID Reg."},{"key":"15855_CR28","doi-asserted-by":"publisher","first-page":"790","DOI":"10.3390\/jpm12050790","volume":"12","author":"MJ Cavaco","year":"2022","unstructured":"Cavaco, M. J. et al. Clinical and genetic risk factors for Drug-Induced liver injury associated with Anti-Tuberculosis Treatment-A study from patients of Portuguese health centers. J. Pers. Med. 12, 790. https:\/\/doi.org\/10.3390\/jpm12050790 (2022).","journal-title":"J. Pers. Med."},{"key":"15855_CR29","doi-asserted-by":"publisher","first-page":"e0286306","DOI":"10.1371\/journal.pone.0286306","volume":"18","author":"DF Ivanice","year":"2023","unstructured":"Ivanice, D. F., Katherine, L. F. & David, A. J. M. Does diabetes mellitus comorbidity increase the risk of drug-induced liver injury during tuberculosis treatment? PLoS One. 18, e0286306. https:\/\/doi.org\/10.1371\/journal.pone.0286306 (2023).","journal-title":"PLoS One"},{"key":"15855_CR30","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1111\/liv.14896","volume":"41","author":"F Jiang","year":"2021","unstructured":"Jiang, F. et al. Incidence and risk factors of anti-tuberculosis drug induced liver injury (DILI): large cohort study involving 4652 Chinese adult tuberculosis patients. Liver Int. 41, 1565\u20131575. https:\/\/doi.org\/10.1111\/liv.14896 (2021).","journal-title":"Liver Int."},{"key":"15855_CR31","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1111\/bcp.14094","volume":"86","author":"AC Drenth-van Maanen","year":"2020","unstructured":"Drenth-van Maanen, A. C., Wilting, I. & Jansen, P. A. F. Prescribing medicines to older people-How to consider the impact of ageing on human organ and body functions. Br. J. Clin. Pharmacol. 86, 1921\u20131930. https:\/\/doi.org\/10.1111\/bcp.14094 (2020).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"15855_CR32","doi-asserted-by":"publisher","first-page":"708522","DOI":"10.3389\/fphar.2021.708522","volume":"12","author":"T Zhong","year":"2021","unstructured":"Zhong, T. et al. An investigation of the risk factors associated with Anti-Tuberculosis Drug-Induced liver injury or abnormal liver functioning in 757 patients with pulmonary tuberculosis. Front. Pharmacol. 12, 708522. https:\/\/doi.org\/10.3389\/fphar.2021.708522 (2021).","journal-title":"Front. Pharmacol."},{"key":"15855_CR33","doi-asserted-by":"publisher","first-page":"e920350","DOI":"10.12659\/msm.920350","volume":"26","author":"H Zhao","year":"2020","unstructured":"Zhao, H., Wang, Y., Zhang, T., Wang, Q. & Xie, W. Drug-Induced liver injury from Anti-Tuberculosis treatment: A retrospective cohort study. Med. Sci. Monit. 26, e920350. https:\/\/doi.org\/10.12659\/msm.920350 (2020).","journal-title":"Med. Sci. Monit."},{"key":"15855_CR34","doi-asserted-by":"publisher","first-page":"135","DOI":"10.5582\/ddt.2020.03029","volume":"14","author":"N Ali","year":"2020","unstructured":"Ali, N., Gupta, N. & Saravu, K. Malnutrition as an important risk factor for drug-induced liver injury in patients on anti-tubercular therapy: an experience from a tertiary care center in South India. Drug Discov Ther. 14, 135\u2013138. https:\/\/doi.org\/10.5582\/ddt.2020.03029 (2020).","journal-title":"Drug Discov Ther."},{"key":"15855_CR35","doi-asserted-by":"publisher","first-page":"1406454","DOI":"10.3389\/fphar.2024.1406454","volume":"15","author":"Q Liu","year":"2024","unstructured":"Liu, Q. et al. Clinical risk factors for moderate and severe antituberculosis drug-induced liver injury. Front. Pharmacol. 15, 1406454. https:\/\/doi.org\/10.3389\/fphar.2024.1406454 (2024).","journal-title":"Front. Pharmacol."},{"key":"15855_CR36","doi-asserted-by":"publisher","unstructured":"Zeleke, A., Misiker, B. & YesufT. A. Drug-induced hepatotoxicity among TB\/HIV co-infected patients in a referral hospital, Ethiopia. BMC Res. Notes. 13 (2). https:\/\/doi.org\/10.1186\/s13104-019-4872-1 (2020).","DOI":"10.1186\/s13104-019-4872-1"},{"key":"15855_CR37","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12916-018-1033-7","volume":"16","author":"CD Tweed","year":"2018","unstructured":"Tweed, C. D. et al. Liver toxicity associated with tuberculosis chemotherapy in the remoxtb study. BMC Med. 16, 46. https:\/\/doi.org\/10.1186\/s12916-018-1033-7 (2018).","journal-title":"BMC Med."},{"key":"15855_CR38","doi-asserted-by":"publisher","first-page":"107003","DOI":"10.1016\/j.micpath.2024.107003","volume":"196","author":"F Zhang","year":"2024","unstructured":"Zhang, F., Zhang, F., Qin, M. & Li, L. Alcohol consumption as a risk factor for anti-tuberculosis drug induced liver injury: A systematic review and meta-analysis. Microb. Pathog. 196, 107003. https:\/\/doi.org\/10.1016\/j.micpath.2024.107003 (2024).","journal-title":"Microb. Pathog"},{"key":"15855_CR39","doi-asserted-by":"publisher","first-page":"e21836","DOI":"10.1371\/journal.pone.0021836","volume":"6","author":"P Shang","year":"2011","unstructured":"Shang, P. et al. Incidence, clinical features and impact on anti-tuberculosis treatment of anti-tuberculosis drug induced liver injury (ATLI) in China. PLoS One. 6, e21836. https:\/\/doi.org\/10.1371\/journal.pone.0021836 (2011).","journal-title":"PLoS One"},{"key":"15855_CR40","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.4102\/sajhivmed.v23i1.1376","volume":"23","author":"MS Moosa","year":"2022","unstructured":"Moosa, M. S. et al. Rechallenge after anti-tuberculosis drug-induced liver injury in a high HIV prevalence cohort. HIV Med. 23, 1376. https:\/\/doi.org\/10.4102\/sajhivmed.v23i1.1376 (2022).","journal-title":"HIV Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-15855-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-15855-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-15855-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T14:16:57Z","timestamp":1756390617000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-15855-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,25]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["15855"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-15855-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,25]]},"assertion":[{"value":"11 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"31309"}}